Drugs / PRP-derived exosomes injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07124871 | Jun 2025 → Feb 2026 overdue | vasculogenic impotence | Institute for the Study of Urological Diseases, Greece | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP-derived exosomes injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07124871 ↗ |